Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Seminars in Hematology|July 15, 2005
Decitabine in myelodysplastic syndromesHussain I Saba, Pierre W WijermansCancer|March 15, 2006
Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patientsBjörn Rüter, Pierre W Wijermans, Michael LübbertInternational Journal of Hematology|October 16, 2004
DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemiaBjörn Rüter, Pierre W Wijermans, Michael LübbertTransfusion|June 26, 2003
The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matchingHenk Schonewille, Annette M van Zijl, Pierre W WijermansJournal of Clinical Apheresis|October 17, 2013
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosisDorothea Evers, Jean-Louis Kerkhoffs, Liane Van Egmond, et al.Nederlands Tijdschrift Voor Geneeskunde|January 27, 2012
[Demethylating medication in myelodysplastic syndrome]Martijn L Manson, Ellen J B Derissen, Pierre W Wijermans, et al.Hemoglobin|October 16, 2004
An alpha-thalassemia phenotype in a Dutch Hindustani, caused by a new point mutation that creates an alternative splice donor site in the first exon of the alpha2-globin geneCornelis L Harteveld, Pierre W Wijermans, Peter van Delft, et al.Cancer Chemotherapy and Pharmacology|March 3, 2012
Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot studyRobert S Jansen, Hilde Rosing, Pierre W Wijermans, et al.Haematologica|October 13, 2005
Serum syndecan-1 in patients with newly diagnosed monoclonal proteinemiaCees G Schaar, Henricus J Vermeer, Pierre W Wijermans, et al.Hemoglobin|October 22, 2008
Hb Lepore-Leiden: a new delta/beta rearrangement associated with a beta-thalassemia minor phenotypeCornelis L Harteveld, Pierre W Wijermans, Sandra G J Arkesteijn, et al.Pageof 5